← Browse by Condition
Medical Condition

essential tremor

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for essential tremor sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — essential tremor Clinical Trials

How many clinical trials are currently recruiting for essential tremor?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for essential tremor, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for essential tremor?
essential tremor research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a essential tremor clinical trial?
Eligibility criteria for essential tremor trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Boston Scientific Corporation 2 trials
Oregon Health and Science University 1 trial
Ruijin Hospital 1 trial
Vanderbilt University Medical Center 1 trial
Boston University Charles River Campus 1 trial

Recruiting Clinical Trials

NCT04828798
Recruiting
Directional Versus Nondirectional DBS for ET
Enrollment
24 pts
Location
United States
Sponsor
Oregon Health and Science Univ...
View Trial →
NCT07774598
Recruiting
Non-Invasive Neuromodulation for Essential Tremor: Long-Term Safety and Effectiveness Study
Enrollment
50 pts
Location
China
Sponsor
Ruijin Hospital
View Trial →
NCT00575081
Recruiting
Physiological Brain Atlas Development
Enrollment
5,000 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
View Trial →
NCT07455760
Recruiting
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
Enrollment
80 pts
Location
United States
Sponsor
Boston University Charles Rive...
View Trial →
NCT04748640 Phase 2, Phase 3
Recruiting
Bilateral Essential Tremor Treatment With Gamma Knife
Enrollment
50 pts
Location
Canada
Sponsor
Université de Sherbrooke
View Trial →
NCT04071847
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Enrollment
1,000 pts
Location
United States, Austr...
Sponsor
Abbott Medical Devices
View Trial →
NCT04032470
Recruiting
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
Enrollment
500 pts
Location
Austria, Belgium, Ca...
Sponsor
Boston Scientific Corporation
View Trial →
NCT03992625
Recruiting
Clinical Outcomes for Deep Brain Stimulation
Enrollment
1,000 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
NCT03664609
Recruiting
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Enrollment
5,000 pts
Location
United States, Belgi...
Sponsor
Boston Scientific Corporation
View Trial →

Related Conditions

dystonia (4) parkinson disease (3) parkinson s disease (1) obsessive compulsive disorder (1) epilepsy (1) parkinson s disease pd (1) movement disorders (1) tremor (1) primary dystonia (1) secondary dystonia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology